Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancerJunichi Hasegawa, Masaki Mori, Tsunekazu Mizushima et al.|Cancer Chemotherapy and Pharmacology|2014Cited by 87